Thursday, August 9, 2012

Oncogene - Table of Contents alert Volume 31 Issue 32

TABLE OF CONTENTS

Volume 31, Issue 32 (August 2012)

In this issue
Original Articles
Short Communication

Also new
AOP

Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Advertisement
Take a look at this article published in Oncogenesis!
Carcinogenesis and cancer progression, driven by mutations in oncogenes and tumor-suppressor genes, result in biological differences between normal and cancer cells in various cellular processes. The results detailed in the article suggest a potential use of GSK-3 inhibitors to selectively kill cancer cells that overexpress GLUT3. GSK-3b modulates GLUT3 expression and cell growth M Watanabe et al OPEN
Oncogenesis
¦ doi:10.1038/oncsis.2012.21 Submit to Oncogenesis and contribute to this new and exciting journal!
 

Original Articles

Top

Regulation of lipid binding underlies the activation mechanism of class IA PI3-kinases

W-C Hon, A Berndt and R L Williams

Oncogene 2012 31: 3655-3666; advance online publication, November 28, 2011; 10.1038/onc.2011.532

Abstract | Full Text

BRCA1 and GATA3 corepress FOXC1 to inhibit the pathogenesis of basal-like breast cancers

D Tkocz, N T Crawford, N E Buckley, F B Berry, R D Kennedy, J J Gorski, D P Harkin and P B Mullan

Oncogene 2012 31: 3667-3678; advance online publication, November 28, 2011; 10.1038/onc.2011.531

Abstract | Full Text

Suppression of Tumorigenicity-14, encoding matriptase, is a critical suppressor of colitis and colitis-associated colon carcinogenesis

P Kosa, R Szabo, A A Molinolo and T H Bugge

Oncogene 2012 31: 3679-3695; advance online publication, December 5, 2011; 10.1038/onc.2011.545

Abstract | Full Text

A protein complex of SCRIB, NOS1AP and VANGL1 regulates cell polarity and migration, and is associated with breast cancer progression

J N Anastas, T L Biechele, M Robitaille, J Muster, K H Allison, S Angers and R T Moon

Oncogene 2012 31: 3696-3708; advance online publication, December 19, 2011; 10.1038/onc.2011.528

Abstract | Full Text

Tumor suppressor Alpha B-crystallin (CRYAB) associates with the cadherin/catenin adherens junction and impairs NPC progression-associated properties

Z Huang, Y Cheng, P M Chiu, F M F Cheung, J M Nicholls, D L-W Kwong, A W M Lee, E R Zabarovsky, E J Stanbridge, H L Lung and M L Lung

Oncogene 2012 31: 3709-3720; advance online publication, December 12, 2011; 10.1038/onc.2011.529

Abstract | Full Text

Abnormal MDMX degradation in tumor cells due to ARF deficiency

X Li, D Gilkes, B Li, Q Cheng, D Pernazza, H Lawrence, N Lawrence and J Chen

Oncogene 2012 31: 3721-3732; advance online publication, November 28, 2011; 10.1038/onc.2011.534

Abstract | Full Text

Short Communication

Top

NPM-ALK signals through glycogen synthase kinase 3β to promote oncogenesis

S R P McDonnell, S R Hwang, V Basrur, K P Conlon, D Fermin, E Wey, C Murga-Zamalloa, Z Zeng, Y Zu, K S J Elenitoba-Johnson and M S Lim

Oncogene 2012 31: 3733-3740; advance online publication, December 19, 2011; 10.1038/onc.2011.542

Abstract | Full Text

Advertisement
Nature Communications #4 in multidisciplinary sciences with first Impact Factor

Nature Communications has joined Nature at the top of the multidisciplinary sciences category with its first impact factor of 7.396*

Launched in April 2010, Nature Communications is a multidisciplinary online journal publishing high quality research across all areas of the natural sciences.

*2011 Journal Citation Reports® (Thomson Reuters, 2012)
 
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: